Kushitani et al demonstrated that for distinguishing between epithelioid mesothelioma and lung adenocarcinoma, the combination of CEA, calretinin and either WT1 or thrombomodulin would form the best panel of immunohistochemical markers (5). This evidence concerns the gene THBD and malignant epithelioid mesothelioma.